[HTML][HTML] SARS-CoV-2: a master of immune evasion

A Rubio-Casillas, EM Redwan, VN Uversky - Biomedicines, 2022 - mdpi.com
Viruses and their hosts have coevolved for a long time. This coevolution places both the
pathogen and the human immune system under selective pressure; on the one hand, the …

[HTML][HTML] An overview of recent insights into the response of TLR to SARS-CoV-2 infection and the potential of TLR agonists as SARS-CoV-2 vaccine adjuvants

MEH Kayesh, M Kohara, K Tsukiyama-Kohara - Viruses, 2021 - mdpi.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led
to coronavirus disease (COVID-19), a global health pandemic causing millions of deaths …

[HTML][HTML] Mechanistic insights into the immune pathophysiology of COVID-19; an in-depth review

A Shafqat, S Shafqat, SA Salameh, J Kashir… - Frontiers in …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which causes
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …

[HTML][HTML] Myeloid-derived suppressor cells as a potential biomarker and therapeutic target in COVID-19

M Rowlands, F Segal, D Hartl - Frontiers in immunology, 2021 - frontiersin.org
Clinical presentations of COVID-19 are highly variable, yet the precise mechanisms that
govern the pathophysiology of different disease courses remain poorly defined. Across the …

[HTML][HTML] Transcriptional changes in CD16+ monocytes may contribute to the pathogenesis of COVID-19

V Chilunda, P Martinez-Aguado, LC Xia… - Frontiers in …, 2021 - frontiersin.org
The COVID-19 pandemic has caused more than three million deaths globally. The severity
of the disease is characterized, in part, by a dysregulated immune response. CD16+ …

Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn

M Shahgolzari, A Yavari, Y Arjeini, SM Miri, A Darabi… - Gene reports, 2021 - Elsevier
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) directly interacts
with host's epithelial and immune cells, leading to inflammatory response induction, which is …

[HTML][HTML] Time-dependent molecular motifs of pulmonary fibrogenesis in COVID-19

JC Kamp, L Neubert, M Ackermann, H Stark… - International Journal of …, 2022 - mdpi.com
(1) Background: In COVID-19 survivors there is an increased prevalence of pulmonary
fibrosis of which the underlying molecular mechanisms are poorly understood;(2) Methods …

PF‐07321332 (Nirmatrelvir) does not interact with human ENT1 or ENT2: Implications for COVID‐19 patients

RK Hau, SH Wright… - Clinical and Translational …, 2022 - Wiley Online Library
The ongoing pandemic of severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2)
and subsequently, coronavirus disease 2019 (COVID‐19), has led to the deaths of over 6.1 …

Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate

E Prieto-Fernández, L Egia-Mendikute… - Emerging Microbes & …, 2021 - Taylor & Francis
ABSTRACT A main clinical parameter of COVID-19 pathophysiology is hypoxia. Here we
show that hypoxia decreases the attachment of the receptor-binding domain (RBD) and the …

[HTML][HTML] The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients

TO Filgueira, PRC Carvalho… - Frontiers in …, 2023 - frontiersin.org
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which induces a high
release of pro-inflammatory chemokines and cytokines, leading to severe systemic …